Research progress on pharmacological action and effective drug carrier of berberine

• 作者: Bai-Jie Ren Dong-Hui Gao Jing-Yi Lu Lei Wang Xin-Ying Zou Yue Liu
• 来源期刊: 海南医科大学学报（英文版）
• 年，卷（期）: 2020,（17）
• 页码范围: 61-65
• 页数: 5页
• 语种: 英文

摘要

Berberine(BBR) is an isoquinoline alkaloid that can be extracted from the traditional Chinese medicine Huang Lian. It has anti-inflammatory, anti-cancer, protection of nerves, hypoglycemic, blood lipid, anti-oxidation, antibacterial and other effects. It can be used clinically to treat chronic colitis, bacterial vaginitis, rheumatoid arthritis, breast cancer, liver cancer, Alzheimer's disease, diabetes, obesity and other common diseases. This paper reviews the pharmacological effects of berberine and the research progress of effective drug carriers in order to provide new ideas for the clinical application of berberine.